European Parliament’s initiatives to support the fight against cancer

Abstract

Correspondence to Ms Stephanie Kohl, Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium; Stephanie.Kohl@eahp.eu The European Parliament (EP) has released a study that sheds light on the current state-of-play in Europe in respect to cancer. Together with Portugal and Slovenia, Germany will work towards continuing to improve the EU’s crisis response, strengthening the Union Civil Protection Mechanism and existing pan-European structures such as the ECDC, as well as promoting the digital exchange of health data, while paying utmost respect to data protection. EMA-HMA Launch joint network strategy The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have developed a joint strategy for the next 5 years detailing how the network of both agencies can continue to enable the supply of safe and effective medicines that meet patients’ needs in the face of challenges posed by ever-accelerating developments in science, medicine, digital technologies, globalisation as well as emerging health threats, such as the COVID-19 pandemic. [...]4 September feedback can be shared on the six priorities areas included in the draft strategy. Public consultation for the EU pharmaceutical strategy In addition to the roadmap consultation – which EAHP featured in its EU Monitor of 9 June 2020 – the European Commission opened a public consultation for its new EU Strategy on safe and affordable medicines. [...]15 of September, members of the public, stakeholders and organisations are encouraged to contribute to this consultation.